Medicare Enrolled

Dr. Thomas Samuel, MD

Medical Oncology · Weston, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
2950 CLEVELAND CLINIC BLVD, Weston, FL 33331
9546595840
Registered in NPPES since 2005
NPI: 1831187947 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Samuel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Samuel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Samuel

Dr. Thomas Samuel is a medical oncology specialist in Weston, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Samuel performed 8,563 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Samuel received a total of $1,549 from 29 pharmaceutical and/or device companies across 79 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Samuel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 45% volume in FL $1,549 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 112945 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
8,563
Medicare services
Top 45% in FL for medical oncology
Not available
Unique patients (not deduplicated)
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Immune globulin infusion (Gammagard)
An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg.
3,250 $36 $279
Iron sucrose injection (Venofer)
An injection of iron sucrose used to replenish iron levels in the body.
2,800 $0 $2
Denosumab injection (Prolia/Xgeva) 1,680 $18 $85
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
380 $136 $404
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
105 $50 $392
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
96 $17 $129
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
80 $12 $134
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
67 $5 $236
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
37 $12 $116
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
25 $99 $298
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
23 $1 $10
New patient office visit, complex (60-74 min) 20 $167 $666
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
40.3% high complexity
54.7% medium
5.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,549
Total received (2019-2024)
Avg $258/year across 6 years
Bottom 28% in FL for medical oncology
29
Companies
79
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$454
2023
$560
2022
$267
2021
$174
2020
$19
2019
$75

Payments by company (2024)

PFIZER INC.
$116
Novartis Pharmaceuticals Corporation
$52
TAIHO ONCOLOGY, INC.
$45
Incyte Corporation
$36
Merck Sharp & Dohme LLC
$32
Genentech, Inc.
$23
Deciphera Pharmaceuticals Inc.
$22
Tempus AI, Inc
$21
Takeda Pharmaceuticals U.S.A., Inc.
$19
AstraZeneca Pharmaceuticals LP
$17
Genentech USA, Inc.
$16
PUMA BIOTECHNOLOGY, INC.
$14
Stemline Therapeutics Inc.
$14
Eisai Inc.
$14
Janssen Biotech, Inc.
$13
Top 3 companies account for 46.9% of 2024 payments
All-time payments by company (2019-2024) ›
Janssen Biotech, Inc.
$318
PFIZER INC.
$244
Novartis Pharmaceuticals Corporation
$131
Merck Sharp & Dohme LLC
$119
TAIHO ONCOLOGY, INC.
$85
Genentech USA, Inc.
$61
AstraZeneca Pharmaceuticals LP
$58
Takeda Pharmaceuticals U.S.A., Inc.
$54
Eisai Inc.
$45
Genentech, Inc.
$44
Coastal Medical Technologies LLC
$38
Incyte Corporation
$36
Daiichi Sankyo Inc.
$29
Amgen Inc.
$24
Deciphera Pharmaceuticals Inc.
$22
Tempus AI, Inc
$21
Pharmacyclics LLC, An AbbVie Company
$21
ImmunoGen, Inc.
$21
Seagen Inc.
$20
Lilly USA, LLC
$18
EISAI INC.
$18
G1 Therapeutics, Inc.
$17
SOBI, INC
$17
Puma Biotechnology, Inc.
$17
Bayer Healthcare Pharmaceuticals Inc.
$17
PUMA BIOTECHNOLOGY, INC.
$14
Stemline Therapeutics Inc.
$14
Astellas Pharma US Inc
$13
Gilead Sciences, Inc.
$12
Top 3 companies account for 44.7% of all-time payments
Associated products mentioned in payments ›
Alecensa · BOSULIF · COSELA · DARZALEX · Doptelet · ENHERTU · Elahere · Enhertu · Fabhalta · IBRANCE · IMBRUVICA · INLYTA · JAKAFI · KEYTRUDA · KISQALI · LONSURF · LUMAKRAS · Lenvima · Lunsumio · MEKINIST · MONJUVI · NINLARO · OXBRYTA · Orserdu · Phesgo · QINLOCK · SCEMBLIX · Stivarga · TECVAYLI · TIVDAK · Tecentriq · VERZENIO · VPRIV · XALKORI · Xospata
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a medical oncology specialist in Weston?
Compare medical oncologists in the Weston area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists in nearby ZIP areas
37
County median income
$74,534
Nearest hospital to ZIP centroid (approximate)
CLEVELAND CLINIC HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Samuel is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Samuel experienced with immune globulin infusion (gammagard)?
Based on Medicare claims data, Dr. Samuel performed 3,250 immune globulin infusion (gammagard) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Samuel receive payments from pharmaceutical companies?
Yes. Dr. Samuel received a total of $1,549 from 29 companies across 79 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Samuel's costs compare to other medical oncologists in Weston?
Dr. Samuel's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Samuel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →